Costs of integrating hepatitis B screening and antiviral prophylaxis into routine antenatal care in Burkina Faso: Treat all versus targeted strategies.
Andréa GossetSeydou DraboPatrizia CarrieriAbdoul Salam Eric TiendrebeogoJeanne Perpétue VincentYasuhito TanakaRoger SombiéHaoua TallDramane KaniaSylvie BoyerYusuke ShimakawaPublished in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)
HBcrAg-RDT minimizes resource use and costs, representing 0.61% of Burkina Faso's 2022 health budget. This study highlights the potential economic feasibility of these strategies and provides valuable resources for conducting cost-effectiveness analyses.